top of page
Search

Prescribing in Pregnancy: Teratogenic Drugs List for MRCP Part 1

TL;DR

Prescribing in Pregnancy: Teratogenic Drugs List is a frequently tested pharmacology topic in MRCP Part 1, particularly in therapeutics and obstetric medicine. Candidates should know the major teratogenic drugs, their characteristic fetal abnormalities, and safer alternatives commonly used in pregnancy. High-yield exam favourites include ACE inhibitors, sodium valproate, warfarin, methotrexate, isotretinoin, and lithium.


Why this topic matters in MRCP Part 1

Teratogenic drug questions are popular because they assess:

  • Applied pharmacology

  • Risk-benefit prescribing

  • Recognition of classic fetal abnormalities

  • Clinical reasoning

  • Safer prescribing alternatives

The examination commonly tests:

  1. Characteristic congenital abnormalities

  2. Timing of exposure

  3. Safer alternatives in pregnancy

  4. Counselling before conception

  5. High-risk chronic disease management


The 5 Most Tested Teratogenic Drugs

1. ACE Inhibitors and ARBs

ACE inhibitors are among the most commonly tested teratogens in MRCP Part 1.

Characteristic fetal effects

  • Renal dysgenesis

  • Oligohydramnios

  • Pulmonary hypoplasia

  • Skull hypoplasia

  • Neonatal renal failure

High-yield exam point

Risk is greatest during the second and third trimesters, although they are generally avoided throughout pregnancy.

Safer alternatives

  • Labetalol

  • Methyldopa

  • Nifedipine

Commonly tested drugs

  • Ramipril

  • Lisinopril

  • Losartan

  • Candesartan

2. Sodium Valproate

A classic neurology and pharmacology favourite.

Associated abnormalities

  • Neural tube defects

  • Spina bifida

  • Craniofacial abnormalities

  • Developmental delay

  • Autism spectrum disorder risk

Exam pearl

Valproate carries one of the highest teratogenic risks among antiepileptic medications.

Safer alternatives

  • Lamotrigine

  • Levetiracetam

  • Specialist neurology review

3. Warfarin

Warfarin embryopathy is frequently examined.

Drug

Characteristic fetal abnormality

Key exam clue

Warfarin

Nasal hypoplasia, stippled epiphyses

Mechanical valve patient

Lithium

Ebstein anomaly

Bipolar disorder

Methotrexate

Craniofacial defects, miscarriage

Rheumatology patient

Isotretinoin

CNS and cardiac defects

Severe acne treatment

Tetracyclines

Tooth discolouration

Antibiotic exposure

Important timing

The greatest risk occurs during weeks 6–12 of gestation.

Safer alternative

  • Low molecular weight heparin (LMWH)

4. Isotretinoin

An important dermatology-associated teratogen.

Associated defects

  • Craniofacial abnormalities

  • Cardiac malformations

  • CNS abnormalities

  • Thymic hypoplasia

High-yield point

Strict pregnancy prevention programmes are mandatory before prescribing isotretinoin.

5. Methotrexate

Frequently tested in rheumatology and gastroenterology.

Characteristic effects

  • Miscarriage

  • Neural tube defects

  • Craniofacial abnormalities

  • Growth restriction

Key clinical point

Methotrexate should be stopped well before conception attempts.


Other High-Yield Teratogenic Drugs

Lithium

Associated abnormality

  • Ebstein anomaly

Carbimazole

Associated abnormalities

  • Aplasia cutis

  • Choanal atresia

Tetracyclines

Effects

  • Tooth discolouration

  • Impaired bone growth

Aminoglycosides

Effects

  • Ototoxicity

Thalidomide

Classical defect

  • Phocomelia

Mycophenolate mofetil

Effects

  • Pregnancy loss

  • Ear and facial abnormalities


10 High-Yield Facts to Remember

  1. ACE inhibitors cause oligohydramnios and fetal renal damage.

  2. Sodium valproate is strongly associated with neural tube defects.

  3. Warfarin embryopathy classically causes nasal hypoplasia.

  4. Lithium is associated with Ebstein anomaly.

  5. Isotretinoin requires strict contraception.

  6. Methotrexate is contraindicated before conception.

  7. Tetracyclines cause tooth discolouration.

  8. Aminoglycosides can cause fetal ototoxicity.

  9. Carbimazole may cause aplasia cutis.

  10. LMWH is preferred instead of warfarin during pregnancy.


The 5 Most Tested Subtopics

1. Antihypertensive prescribing in pregnancy

Know safe and unsafe agents thoroughly.

Safe

  • Labetalol

  • Methyldopa

  • Nifedipine

Unsafe

  • ACE inhibitors

  • ARBs

2. Antiepileptic drugs

Valproate is the highest-yield drug.

Candidates should also know:

  • Folic acid supplementation

  • Pre-conception counselling

  • Safer alternatives

3. Anticoagulation

Understand:

  • Warfarin embryopathy

  • LMWH indications

  • Mechanical valve scenarios

4. Rheumatology drugs

Frequently tested:

  • Methotrexate

  • Mycophenolate

  • Cyclophosphamide

5. Dermatology prescribing

Classic association:

  • Isotretinoin → severe congenital malformations


Practical Mini-Case

A 28-year-old woman with epilepsy presents at 9 weeks’ gestation. She has been taking sodium valproate for several years.

Which congenital abnormality is most strongly associated with this medication?

A. Ebstein anomalyB. Neural tube defectC. Tooth discolourationD. Nasal hypoplasiaE. Limb hypoplasia

Answer: B. Neural tube defect

Explanation

Sodium valproate is strongly associated with neural tube defects, particularly spina bifida. This is one of the highest-yield teratogenic drug associations in MRCP Part 1.

  • Ebstein anomaly → Lithium

  • Tooth discolouration → Tetracyclines

  • Nasal hypoplasia → Warfarin

  • Limb hypoplasia → Thalidomide

Practise more high-yield pharmacology questions here:


Medical trainee studying prescribing in pregnancy and teratogenic medications for MRCP Part 1

Practical Study Checklist

Before the examination, ensure you can:

  • Match each teratogenic drug to its classic fetal abnormality

  • Recall safer alternatives

  • Recognise trimester-specific risks

  • Distinguish embryopathy from fetopathy

  • Identify common prescribing traps

  • Apply knowledge to clinical scenarios

  • Recall counselling principles

  • Recognise dermatology-associated teratogens

  • Understand anticoagulation choices

  • Revise common antiepileptic drugs thoroughly

For structured revision lectures:


Common Pitfalls

  • Confusing lithium-associated defects with valproate embryopathy

  • Forgetting ACE inhibitors are particularly dangerous later in pregnancy

  • Assuming all antiepileptic drugs have equal risk

  • Mixing up warfarin embryopathy with fetal alcohol syndrome

  • Forgetting methotrexate must be stopped before conception


FAQs

Which teratogenic drugs are most commonly tested in MRCP Part 1?

ACE inhibitors, sodium valproate, warfarin, methotrexate, lithium, and isotretinoin are the most commonly tested drugs. Candidates should know both fetal abnormalities and safer alternatives.

Why is sodium valproate considered dangerous during pregnancy?

Valproate is strongly associated with neural tube defects and neurodevelopmental disorders. It carries one of the highest teratogenic risks among antiepileptic drugs.

Is warfarin always contraindicated in pregnancy?

Warfarin is generally avoided because of fetal embryopathy risk, especially during the first trimester. LMWH is usually preferred.

Which antihypertensive drugs are considered safe in pregnancy?

Labetalol, methyldopa, and nifedipine are commonly used during pregnancy. ACE inhibitors and ARBs should be avoided.

How should I revise teratogenic drugs for MRCP Part 1?

Focus on pattern recognition:

  • Drug

  • Characteristic abnormality

  • Safer alternative

Combining tables with MCQ practice improves retention significantly.


Ready to start?

Mastering pharmacology is essential for success in MRCP Part 1. Build a complete revision strategy using Crack Medicine resources:


Sources

  1. MRCP(UK) Examination Blueprint


    https://www.mrcpuk.org/mrcpuk-examinations/part-1

  2. NICE Guidance: Hypertension in Pregnancy


    https://www.nice.org.uk/guidance/ng133

  3. British National Formulary (BNF)


    https://bnf.nice.org.uk/

  4. UK Teratology Information Service (UKTIS)


    https://www.uktis.org/

  5. Royal College of Obstetricians and Gynaecologists


    https://www.rcog.org.uk/


 
 
 

Comments


bottom of page